CAMBRIDGE NUTRITIONAL SCIENCES PLC Cambridge Nutritional Sciences plc Stock
Equities
ODX
GB00B1VCP282
Medical Equipment, Supplies & Distribution
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 4.1 GBX | +2.50% |
|
+2.50% | +70.83% |
| May. 24 | Cambridge Nutritional Sciences appoints James Copper as COO | AN |
| May. 24 | Cambridge Nutritional Sciences Names COO | MT |
| Sales 2024 * | 9M 11.46M | Sales 2025 * | - | Capitalization | 9.76M 12.43M |
|---|---|---|---|---|---|
| Net income 2024 * | -1M -1.27M | Net income 2025 * | - | EV / Sales 2024 * | 0.62 x |
| Net cash position 2024 * | 4.2M 5.35M | Net cash position 2025 * | - 0 | EV / Sales 2025 * | - |
| P/E ratio 2024 * |
-8.2
x | P/E ratio 2025 * |
-
| Employees | 91 |
| Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 90.83% |
More Fundamentals
* Assessed data
More news
Latest transcript on Cambridge Nutritional Sciences plc
More press releases
| 1 day | +2.50% | ||
| 1 week | +2.50% | ||
| Current month | +5.13% | ||
| 1 month | +2.50% | ||
| 3 months | +54.72% | ||
| 6 months | +49.09% | ||
| Current year | +70.83% |
1 week
3.90
4.20
1 month
3.704.20
Current year
2.304.20
1 year
1.664.20
3 years
1.6678.00
5 years
1.66126.95
10 years
1.66126.95
| Managers | Title | Age | Since |
|---|---|---|---|
Jag Grewal
CEO | Chief Executive Officer | 54 | 11-06-29 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Jag Grewal
CEO | Chief Executive Officer | 54 | 11-06-29 |
Jeremy Millard
BRD | Director/Board Member | 53 | 19-02-28 |
Carolyn Rand
CHM | Chairman | 60 | 23-08-16 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-05-24 | 4.1 | +2.50% | 1,187,310 |
| 24-05-23 | 4 | 0.00% | 485,738 |
| 24-05-22 | 4 | 0.00% | 77,433 |
| 24-05-21 | 4 | 0.00% | 651,981 |
| 24-05-20 | 4 | 0.00% | 1,070,587 |
Delayed Quote London S.E., May 24, 2024 at 11:35 am EDT
More quotes
Cambridge Nutritional Sciences plc is a United Kingdom-based specialist medical diagnostics company. The Company develops, manufactures and markets diagnostic products associated with food sensitivity and gut health. The Company serves healthcare professionals and the consumer directly with a focus on health and nutrition products.
Calendar
Trading Rating
Investor Rating
ESG Refinitiv
EPS Revisions
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| +70.83% | 12.1M | |
| -4.92% | 12.11B | |
| -5.82% | 8.07B | |
| +5.43% | 5.67B | |
| +26.16% | 5.48B | |
| -9.58% | 4.12B | |
| -59.63% | 2.75B | |
| +8.44% | 2.62B | |
| -3.70% | 2.33B | |
| +21.00% | 2.11B |
- Stock Market
- Equities
- ODX Stock
